Micromethod for plasma cefuroxime quantification through high performance liquid chromatography. Application to the prophylaxy of patients submitted to cardiac surgery;Micrométodo para quantificação de cefuroxima em plasma através da cromatografia líquida de alta eficiência. Aplicação na profilaxia de pacientes submetidos à cirurgia cardíaca

Revista Brasileira de Ciencias Farmaceuticas/Brazilian Journal of Pharmaceutical Sciences

Volumn 39, Issue 3, 2003, Pages 265-272

  Nascimento, Jorge Willian Leandro ^a   Etsuco Omosako, Célia ^a   Carmona, Maria José ^a   Otávio Auler Jr , José ^a   Jorge Santos, Silvia Regina Cavani ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cefuroxime; Heart surgery; HPLC UV; Plasma; Prophylaxis

Indexed keywords

ACETONITRILE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; VANCOMYCIN;

ACCURACY; ADULT; ANALYTICAL ERROR; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; DRUG BLOOD LEVEL; ELUTION; FEMALE; HEART SURGERY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPOTHERMIA; INFECTION; MALE; PH; POSTOPERATIVE PERIOD; STANDARD; VALIDATION PROCESS;

EID: 0345283061     PISSN: 15169332     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. AZIZ, N. S.; GAMBERTOGLIO, J. G.; LIN, E. T.; GRAUSZ, H.; BENET, L. Z. Pharmacokinetics of cefamandole using a HPLC assay. J. Pharm. Biopharm., Shannon, v.6, n.2, p.153-164, 1978.
2. BERNARD, A.; PILLET, M.; GOUDET, P.; VIARD, H. Antibiotic prophylaxis in pulmonary surgery: a prospective randomized double-blind trial of flash cefuroxime versus forty-eight-hour cefuroxime. J. Thorac. Cardiovasc. Surg., Saint Louis, v. 107, n.3, p.896-900, 1994.
3. BRISSON, A. M.; FOURTILLAN, J. B. Determination of cephalosporins in biological material by reversed-phase liquid column chromatography. J. Chromatogr., Amsterdam, v.223, p.393-399, 1981.
4. BUNDTZEN, R. W.; TOOTHAKER, R. D.; NIELSON, O. S.; MADSEN, P. O.; WELLING, P. G.; CRAIG, W. A. Pharmacokinetics of cefuroxime in normal and impaired renal function: comparison of high-pressure liquid chromatography and microbiological assays. Antimicrob. Agents Chemother., Washington, v. 19, n.3, p.443-449, 1981.
5. DAS GUPTA, V. Stability of cefotaxime sodium as determined by high-performance liquid chromatography. J. Pharm. Sci., New York, v.73, n.4, p.565-567, 1984.
6. DELLAMONICA, P. Cefuroxime axetil. Int. J. Antimicrob. Agents, Amsterdam, v.4, n. 1, p.23-36, 1994.
7. EL OAKLEY, R.; PAUL, E.; WONG, P. S. Mediastinitis in patients undergoing cardiopulmonary bypass: risk analysis and midterm results. J. Cardiovasc. Surg., Torino, v.38, p.595-600, 1998.
8. EMMERSON, A. M. Cefuroxime axetil. J. Antimicrob. Chemother., Oxford, v.22, n.2, p.101-104, 1988.
9. FABRE, H.; EDDINE, N. H.; BERGE, G. Degradation kinetics in aqueous solution of cefotaxime sodium, a third-generation cephalosporin. J. Pharm. Sci., New York, v.73, n.5, p.611-739, 1984.
10. GARTON, A. M.; RENNIE, R. P.; GILPIN, J.; MARRELLI, M.; SHAFRAN, S. D. Comparison of dose doubling with probenecid for sustaining serum cefuroxime levels. J. Antimicrob. Chemother., Oxford, v.40, n.6, p.903-906, 1997.
11. HOLT, D. E.; LOUVOIS, J.; HURLEY, R.; HARVEY, D. A high performance liquid chromatography system for the simultaneous assay of some antibiotics commonly found in combination in clinical samples. J. Antimicrob. Chemother, Oxford, v.26, p. 107-115, 1990.
12. JACOB, H. G.; BORNEFF-LIPP, M.; BACH, A.; PUCKLER, S.; WINDELER, J.; SONNTAG, H.; HAGL, S. The endogenous pathway is a major route for deep sternal wound infection. Eur. J. Cardio-Thorac. Surg., Heidelberg, v. 17, p. 154-160, 2000.
13. KAUKONEN, J. P.; TUOMAINEN, P.; MAKIJARVI, J.; MOKKA, R.; MANNISTO, P. T. Intravenous cefuroxime prophylaxis. Acta Orthop. Scand., Copenhagen, v.66, n.1, p. 14-16, 1995.
14. KRIARAS, I.; MICHALOPOULOS, A.; MICHALIS, A.; PALATIANOS, G.; ECONOMOPOULOS, G.; ANAGNOSTOPOULOS, C.; GEROULANOS, S. Antibiotic prophylaxis in cardiac surgery. J. Cardiovasc. Surg., Torino, v.38, n.6, p.605-610, 1997.
15. LORENZ, L. J.; BASHORE, F. N.; OLSEN, B. A. Determination of process-related impurities and degradation products in cefaclor by high-performance liquid chromatography. J. Chromatogr. Sci., Niles, v.30, p.211-216, 1992.
16. NILSSON-EHLE, I.; NILSSON-EHLE, P. Liquid chromatographic assay of cefuroxime in serum. Clin. Chem., Washington, v.24, n.2, p.365-367, 1978.
17. PERRY, C. M.; BROGDEN, R. N. Cefuroxime axetil: a review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy. Drugs, Auckland, v. 52, n.1, p.125-158, 1996.
18. SCIACCHITANO, C. J.; MOPPER, B.; SPECCHIO, J. Identification and separation of five cephalosporins by micellar eletrokinetic capillary chromatography. J. Chromatogr. B: Biomed. Sci. Appl., Amsterdam, v.657, n.2, p.395-399, 1994.
19. SU, K. S. E.; QUAY, J. F.; CAMPANALE, K. M.; STUCKY, J. F. Nonaqueous cephalosporin suspension for parenteral administration: cefazolin sodium. J. Pharm. Sci., New York, v.73, n.11, p.1602-1606, 1984.
20. TARTAGLIONE, T. A.; POLK, R. E. Review of the new second-generation cephalosporins: cefonicid, ceforanide, and cefuroxime. Drug Intell. Clin. Pharm., Hamilton, v.19, n.3, p.188-198, 1985.
21. TRICK, W. E.; SCHECKLER, W. E.; TOKARS, J. I.; JONES, K. C.; RAPPEN, M. L.; SMITH, E. M.; JARVIS, W. R. Modifiable risk factors associated with deep sternal site infection after coronary artery bypass grafting. J. Thorac. Cardiovasc. Surg., Saint Louis, v. 119, p.108-114, 2000.
22. VUORISALO, S.; POKELA, R.; SYRJÄLÄ, H. Comparison of vancomycin and cefuroxime for infection prophylaxis in coronary artery bypass surgery. Infect. Control Hosp. Epidemiol., Thorofare, v. 19, n.4, p.234-239, 1998.
23. WELLENS, F.; PIRLET, M.; LARBUISSON, R.; DE MEIRELEIRE, F.; DE SOMER, P. Prophylaxis in cardiac surgery: a controlled randomized comparison between cefazolin and cefuroxime. Eur. J. Cardio. Thorac. Surg., Heidelberg, v.9, n.6, p.325-329, 1995.